Your Shopping Cart Is Empty
| Report Code: A03141 | Aug 2021 | Pages: 178 | ||
| Tables: 84 | Charts: 19 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Intravenous Infusion Pump Market
Request Now !The global intravenous infusion pump market was valued at $4,154.30 million in 2020, and is estimated to reach $8,147.20 million by 2030, growing at a CAGR of 7.10% from 2021 to 2030.Intravenous infusion pump is a medical device used to infuse medications or nutrients into a patient’s circulatory system. These are commonly found in a medical settings, as they are widely used in transferring medications in accurate dosages.
The COVID-19 pandemic has led to an increase in the demand for intravenous infusion pumps and related systems, as majority of the hospitalized patients, especially those in ICUs, are medicated via intravenous infusion pumps due to their ability to deliver precise doses automatically at set times.
The key factors that drive the growth of the global intravenous infusion pump market are increase in geriatric population and rise in prevalence of chronic diseases. In addition, surge in adoption of portable infusion pumps to reduce hospital expenditure is expected to supplement the growth. However, patient safety risks and medication errors related to infusion pumps restrict the intravenous infusion pump market growth. Conversely, technological advancements in infusion pumps are expected to create lucrative opportunities for key market players during the forecast period.
Infusion pumps such as ambulatory chemotherapy pumps, implantable pumps, and insulin pumps are useful for managing various diseases, such as cancer and diabetes, in home care settings. Furthermore, ambulatory infusion pumps are designed to be portable or wearable. In addition, infusion pumps are used to deliver fluids such as nutrients, medicines, and antibiotics in a patient’s body precisely and under a controlled environment. They are commonly used in hospitals, ambulatory surgery centers, home settings, infusion clinics, and long-term care facilities. In the last few years, the demand for home healthcare has increased significantly, owing to high prevalence of chronic diseases and rise in healthcare expenditure, majorly on hospitalization. Home healthcare provides patients with an affordable option compared to expensive hospital care, which, in turn, helps reduce the public expenditure on healthcare services. With the increasing need to reduce hospital stays, patients are increasingly adopting ambulatory infusion pumps that are cheaper than most other infusion pumps as well as easier to use. Thus, all these factors collectively boost the demand for infusion pump products, thereby augmenting the intravenous infusion pump market growth.
Infusion pumps and ventilators can be considered critical devices, as these devices are used in ICUs, CCUs, and emergency departments. IV infusion is a common need in COVID wards. Infusion pumps are used in hospitals and other emergency centers to control and deliver doses of medication, and because they can be set to do this without constant supervision, they allow doctors and nurses to treat patients with minimal exposure to infection. Hence, the demand for infusion pumps grew significantly in 2020. This made the supply and distribution of infusion pumps a major challenge.
Owing to increase in spending on long-term care, the preference for homecare settings has been rising substantially. Ambulatory infusion pumps in homecare settings are more in demand due to rise in expenditure majorly on hospitalization and increase in prevalence of chronic diseases. Increase in the rate of adopting ambulatory infusion pumps and rise in need to reduce hospital stays are critical factors for surge in demand for ambulatory infusion pumps in homecare settings.
Intrvenous Infusion Pump Market Segmentation
The global Intravenous infusion pump market is segmented into type, application, end user and region. By type, the market is categorized into volumetric infusion pumps, syringe infusion pumps, and patient controlled analgesia infusion pumps. The applications covered in the study include oncology, parenteral nutrition, analgesia/pain management, and others. On the basis of end user, the market is segregated into hospitals & clinics, home healthcare, and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Depending on type, the volumetric infusion pumps segment was the major revenue contributor in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in adoption of technologically advanced volumetric infusion pumps that exhibit the capabilities such as electronic health record (EHR) integration, built-in safety systems, as well as drug library, which is a list of drugs stored in the smart pump’s memory, serving as a key tool to prevent medication errors. Moreover, as the socio-economic prospect of developing countries is improving, more people are expected to be able to opt for the use of volumetric pumps in home healthcare, which is the key driving factor of the volumetric infusion pump segment. On the basis of application, the oncology segment led the market in 2020, and is anticipated to maintain its lead during the forecast period. This is attributed to rise in prevalence of cancer, as these pumps are extensively used to administer drugs during treatment of these diseases.
On the basis of end user, the hospitals & clinics segment led the market in 2020, and is anticipated to maintain its lead during the forecast period. This is attributed to the availability of smart and advanced intravenous infusion pumps in hospitals along with high prevalence of chronic diseases and rise in healthcare expenditure.
North America was the largest shareholder in the global intravenous infusion pump market in 2020, owing to its well-established healthcare infrastructure, favorable reimbursement, high chronic disease burden, advancements in infusion technology, and supportive government regulations for product commercialization. However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period, owing to alarming rise in burden of chronic diseases such as cancer & diabetes, surge in number of surgical procedures performed, rapid adoption of innovative medical devices, and the regional presence of major global players.
Some of the major companies that operate in the global intravenous infusion pump market are F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Medtronic, Smith Medical, ICU Medical, Inc., and Tandem Diabetes Care, Inc.
Key Benefits For Stakeholders
Key Market Segments
By Type
By Application
By End User
By Region
KEY MARKET PLAYERS
Intravenous Infusion Pump Market Report Highlights
| Aspects | Details |
|---|---|
| By TYPE |
|
| By APPLICATION |
|
| By END USER |
|
| By Region |
|
| Key Market Players | Terumo Corporation, Tandem Diabetes Care, Inc., ICU Medical, Inc., Baxter International, Inc., F. Hoffmann-La Roche Ltd., Smith Medical, B. Braun Holding GmbH & Co. KG, Fresenius SE & Co. KGaA, Medtronic, Becton, Dickinson and Company |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models]
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.3.1.Top player positioning
3.4.Market dynamics
3.4.1.Drivers, restraints, and opportunity
3.4.2.Drivers
3.4.2.1.Increasing prevalence of chronic diseases and rising demand for ambulatory infusion pumps in home care settings
3.4.2.2.Technological advancements leading to products with improved features
3.4.2.3.Rising demand for ambulatory infusion pumps in homecare settings
3.4.3.Restraints
3.4.3.1.Product recalls
3.4.4.Opportunity
3.4.4.1.Emerging economies to offer growth opportunities
3.5.Impact of COVID-19 on intravenous infusion pump market
3.5.1.Overview
3.5.2.Impact analysis
CHAPTER 4:INTRAVENOUS INFUSION PUMP MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Volumetric Infusion Pumps
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Syringe Infusion Pumps
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Patient Controlled Analgesia Infusion Pumps
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Oncology
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Parenteral Nutrition
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Analgesia/Pain Management
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Others
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
CHAPTER 6:INTRAVENOUS INFUSION PUMP MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals & Clinics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Home Healthcare
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Others
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:INTRAVENOUS INFUSION PUMP MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key opportunities and forecast
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by type
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by end user
7.2.5.1.U.S.
7.2.5.1.1.U.S. market size and forecast, by type
7.2.5.1.2.U.S. market size and forecast, by application
7.2.5.1.3.U.S. market size and forecast, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada market size and forecast, by type
7.2.5.2.2.Canada market size and forecast, by application
7.2.5.2.3.Canada market size and forecast, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico market size and forecast, by type
7.2.5.3.2.Mexico market size and forecast, by application
7.2.5.3.3.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key opportunities and forecast
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by type
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by end user
7.3.5.1.Germany
7.3.5.1.1.Germany market size and forecast, by type
7.3.5.1.2.Germany market size and forecast, by application
7.3.5.1.3.Germany market size and forecast, by end user
7.3.5.2.France
7.3.5.2.1.France market size and forecast, by type
7.3.5.2.2.France market size and forecast, by application
7.3.5.2.3.France market size and forecast, by end user
7.3.5.3.UK
7.3.5.3.1.UK market size and forecast, by type
7.3.5.3.2.UK market size and forecast, by application
7.3.5.3.3.UK market size and forecast, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy market size and forecast, by type
7.3.5.4.2.Italy market size and forecast, by application
7.3.5.4.3.Italy market size and forecast, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain market size and forecast, by type
7.3.5.5.2.Spain market size and forecast, by application
7.3.5.5.3.Spain market size and forecast, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe market size and forecast, by type
7.3.5.6.2.Rest of Europe market size and forecast, by application
7.3.5.6.3.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key opportunities and forecast
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by type
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by end user
7.4.5.1.Japan
7.4.5.1.1.Japan market size and forecast, by type
7.4.5.1.2.Japan market size and forecast, by application
7.4.5.1.3.Japan market size and forecast, by end user
7.4.5.2.China
7.4.5.2.1.China market size and forecast, by type
7.4.5.2.2.China market size and forecast, by application
7.4.5.2.3.China market size and forecast, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia market size and forecast, by type
7.4.5.3.2.Australia market size and forecast, by application
7.4.5.3.3.Australia market size and forecast, by end user
7.4.5.4.India
7.4.5.4.1.India market size and forecast, by type
7.4.5.4.2.India market size and forecast, by application
7.4.5.4.3.India market size and forecast, by end user
7.4.5.5.Rest of Asia-Pacific
7.4.5.5.1.Rest of Asia-Pacific market size and forecast, by type
7.4.5.5.2.Rest of Asia- Pacific market size and forecast, by application
7.4.5.5.3.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key opportunities and forecast
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by type
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by end user
7.5.5.1.Brazil
7.5.5.1.1.Brazil market size and forecast, by type
7.5.5.1.2.Brazil market size and forecast, by application
7.5.5.1.3.Brazil market size and forecast, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia market size and forecast, by type
7.5.5.2.2.Saudi Arabia market size and forecast, by application
7.5.5.2.3.Saudi Arabia market size and forecast, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa market size and forecast, by type
7.5.5.3.2.South Africa market size and forecast, by application
7.5.5.3.3.South Africa market size and forecast, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA market size and forecast, by type
7.5.5.4.2.Rest of LAMEA market size and forecast, by application
7.5.5.4.3.Rest of LAMEA market size and forecast, by end user
LIST OF TABLES
TABLE 01.INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)
TABLE 02.INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR VOLUMETRIC INFUSION PUMPS, BY REGION, 2020–2030($MILLION)
TABLE 03.INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR SYRINGE INFUSION PUMPS, BY REGION, 2020–2030($MILLION)
TABLE 04.INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR PATIENT CONTROLLED ANALGESIA INFUSION PUMPS, BY REGION, 2020–2030($MILLION)
TABLE 05.INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY APPLICATION, 2020–2030($MILLION)
TABLE 06.INTRAVENOUS INFUSION PUMP MARKET FOR ONCOLOGY REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 07.PARENTERAL NUTRITION FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 08.ANALGESIA/PAIN MANAGEMENT FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 09.OTHERS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 10.INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 11.INTRAVENOUS INFUSION PUMP MARKET FOR HOSPITALS & CLINICS REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 12.INTRAVENOUS INFUSION PUMP MARKET FOR HOME HEALTHCARE REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 13.INTRAVENOUS INFUSION PUMP MARKET FOR OTHERS REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 14.INTRAVENOUS INFUSION PUMP MARKET, BY REGION, 2020–2030($MILLION)
TABLE 15.NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 16.NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 17.NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 18.NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 19.U.S. INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 20.U.S. INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 21.U.S. INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 22.CANADA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 23.CANADA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 24.CANADA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 25.MEXICO INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 26.MEXICO INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 27.MEXICO INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 28.EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 29.EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 30.EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 31.EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 32.GERMANY INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 33.GERMANY INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 34.GERMANY INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 35.FRANCE INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 36.FRANCE INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 37.FRANCE INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 38.UK INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 39.UK INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 40.UK INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 41.ITALY INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 42.ITALY INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 43.ITALY INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 44.SPAIN INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 45.SPAIN INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 46.SPAIN INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 47.REST OF EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 48.REST OF EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 49.REST OF EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 50.ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 51.ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 52.ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 53.ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 54.JAPAN INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 55.JAPAN INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 56.JAPAN INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 57.CHINA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 58.CHINA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 59.CHINA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 60.AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 61.AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 62.AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 63.INDIA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 64.INDIA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 65.INDIA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 66.REST OF ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 67.REST OF ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 68.REST OF ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 69.LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 70.LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 71.LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 72.LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 73.BRAZIL INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 74.BRAZIL INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 75.BRAZIL INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 76.SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 77.SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 78.SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 79.SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 80.SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 81.SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
TABLE 82.REST OF LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 83.REST OF LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 84.REST OF LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020–2030($MILLION)
LIST OF FIGURES
FIGURE 01.GLOBAL INTRAVENOUS INFUSION PUMP MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.TOP PLAYER POSITIONING, 2020
FIGURE 09.DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 10.INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2020–2030(%)
FIGURE 11.INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR SYRINGE INFUSION PUMPS, BY COUNTRY, 2020–2030(%)
FIGURE 12.INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR PATIENT CONTROLLED ANALGESIA INFUSION PUMPS, BY COUNTRY, 2020–2030(%)
FIGURE 13.ONCOLOGY FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 14.PARENTERAL NUTRITION FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 15.ANALGESIA/PAIN MANAGEMENT FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 16.OTHERS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 17.HOSPITALS & CLINICS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 18.HOME HEALTHCARE FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 19.OTHERS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020–2030(%)
The intravenous infusion pump market gained prominence in 2020, and is expected to witness a significant rise in the near future. This is attributed to increase in prevalence of chronic diseases & disorders, continuous product commercialization, market availability & product affordability, and rise in public awareness related to preventive care. However, lack of reimbursement policy is expected to hamper the market growth.
The intravenous infusion pump market has piqued the interest of healthcare providers, owing to numerous benefits offered by these devices to treat several clinical disorders. There have been remarkable technological advancements to provide advanced treatment options for the management of cardiovascular diseases. As the market is saturated with steady growth rate in developed nations, Asia-Pacific and LAMEA are expected to offer high growth opportunities to the key players.
Other key factors likely to drive the demand for these products are rise in prevalence of cancer and rapid increase in the aging population globally. In addition, upsurge in adoption of portable infusion pumps and improvement of healthcare infrastructure in emerging countries supplement the market growth.
A. The total market value of intravenous infusion pump marketis $4,154.30 million in 2020.
A. The forcast period for intravenous infusion pump marketis 2021 to 2030
A. The market value of intravenous infusion pump marketin 2030 is $8,147.20 million.
A. The base year is 2020 in intravenous infusion pump market
A. Top companies such as,Acadia Healthcare, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Medtronic, Smith Medical, ICU MEDICAL, INC., Tandem Diabetes Care, Inc held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. By type volumetric infusion pumps segment is the most influencing segment. The growing trend of adoption of technologically advanced volumetric infusion pumps that possess capabilities such as EHR integration, build-in safety systems as well as drug libraries and others. Moreover, as the socio-economic prospect of developing countries improving, more people are expected to be able to opt for the use of volumetric pumps in home healthcare are the key driving factors in the volumetric infusion pump segment.
A. The major factor that fuels the growth of the global intravenous infusion pump market includes, Increasing prevalence of chronic diseases and rising demand for ambulatory infusion pumps in home care settings, Technological advancements leading to products with improved features, Rising demand for ambulatory infusion pumps in homecare settings drive the growth of the global Intravenous infusion pump market. However, product recalls is expected to hamper the market growth.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to to increase in health awareness, development in health care infrastructure, and rise in the number of hospitals equipped with advanced medical facilities.
A. An infusion pump is a medical device that delivers fluids, such as nutrients and medications, into a patient’s body in controlled amounts. Infusion pumps are in widespread use in clinical settings such as hospitals, nursing homes, and in the home
A. oncology, parenteral nutrition, analgesia/pain management and others
Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report